We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EKTA-B.ST

Price
63.25
Stock movement up
+2.10 (3.43%)
Company name
Elekta AB (publ)
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Devices
Market cap
23.22B
Ent value
40.39B
Price/Sales
1.32
Price/Book
2.73
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
79.52
Forward P/E
15.74
PEG
-
EPS growth
-26.22%
1 year return
3.52%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2026-01-16

DIVIDENDS

EKTA-B.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E79.52
Price to OCF7.22
Price to FCF10.40
Price to EBITDA11.55
EV to EBITDA20.08

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.32
Price to Book2.73
EV to Sales2.30

FINANCIALS

Per share

Loading...
Per share data
Current share count367.10M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)4.02

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.58B
Net receivables7.37B
Total current assets13.03B
Goodwill0.00
Intangible assets11.81B
Property, plant and equipment1.74B
Total assets28.24B
Accounts payable1.59B
Short/Current long term debt7.60B
Total current liabilities12.56B
Total liabilities19.74B
Shareholder's equity8.49B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open61.30
Daily high66.70
Daily low60.90
Daily Volume2.83M
All-time high143.00
1y analyst estimate56.15
Beta1.08
EPS (TTM)-
Dividend per share0.00
Ex-div date5 Mar 2026
Next earnings date5 Mar 2026

Downside potential

Loading...
Downside potential data
EKTA-B.STS&P500
Current price drop from All-time high-55.77%-0.50%
Highest price drop-71.58%-19.00%
Date of highest drop29 Jul 20258 Apr 2025
Avg drop from high-61.72%-2.50%
Avg time to new high-6 days
Max time to new high315 days89 days
COMPANY DETAILS
EKTA-B.ST (Elekta AB (publ)) company logo
Marketcap
23.22B
Marketcap category
Large-cap
Description
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Employees
4484
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As the European markets begin 2026 on a high note, with the STOXX Europe 600 Index climbing 2.27% amid optimism about economic growth and favorable interest rates, investors are increasingly focused o...
January 16, 2026
As the pan-European STOXX Europe 600 Index reaches new highs, buoyed by an improving economic environment, investors are increasingly on the lookout for stocks that may be trading below their intrinsi...
January 8, 2026
As the pan-European STOXX Europe 600 Index reaches new highs, buoyed by an improving economic environment and closing 2025 with its strongest yearly performance since 2021, investors are increasingly ...
January 8, 2026
BOCA RATON, Fla., January 07, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments fo...
January 7, 2026
In a holiday-shortened week, the pan-European STOXX Europe 600 Index ended slightly higher, nearing record levels amid optimism about future earnings and economic prospects. As investors navigate this...
December 30, 2025
As global markets continue to show resilience with U.S. indices hitting record highs and positive sentiment buoyed by economic growth and AI optimism, investors are keenly observing opportunities for ...
December 30, 2025
As the pan-European STOXX Europe 600 Index closes just shy of a record high amid positive sentiment about future earnings and economic prospects, investors are keenly observing opportunities within th...
December 30, 2025
As European markets navigate a mixed landscape with the pan-European STOXX Europe 600 Index ending slightly lower and major indexes showing varied performance, investors are keenly observing the Europ...
December 18, 2025
Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo is now available in India, bringing high-defin...
December 5, 2025
As European markets experience a positive momentum, with the STOXX Europe 600 Index and major country-specific indexes seeing gains, investors are increasingly focused on identifying stocks that may b...
December 1, 2025
Next page